Bactericidal fully human single‐chain fragment variable antibodies protect mice against methicillin‐resistant <i>Staphylococcus</i><i>aureus</i> bacteraemia

Abstract

The combination therapy with anti-<i>S</i>. <i>aureus</i> scFvs and conventional antibiotics might shed light on the treatment of patients with <i>S. aureus</i> infections.